|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.350 EUR | +6.35% |
|
-2.62% | +56.54% |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors |  |
| 06-22 | THX Pharma Announces Appointment of Sophie Jacq Lapointe to Board of Directors | CI |
| Market Cap | 46.22M 52.8M 42.63M 39.81M 75.01M 4.99B 76.65M 513M 198M 2.46B 198M 194M 8.55B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 22.52M 25.72M 20.77M 19.4M 36.55M 2.43B 37.34M 250M 96.51M 1.2B 96.6M 94.49M 4.17B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.97% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +6.35% | ||
| 1 week | -2.62% | ||
| Current month | -10.43% | ||
| 1 month | -9.95% | ||
| 3 months | +10.93% | ||
| 6 months | +71.36% | ||
| Current year | +56.54% |
| 1 week | 3.12 |  | 3.4 |
| 1 month | 3.04 | | 4.1 |
| Current year | 1.83 | | 5.1 |
| 1 year | 0.97 | | 5.1 |
| 3 years | 0.26 | | 5.1 |
| 5 years | 0.26 | | 10.88 |
| 10 years | 0.26 | | 23.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-31 | |
Christine Placet
DFI | Director of Finance/CFO | - | 2024-03-31 |
Marie Sebille
CTO | Chief Tech/Sci/R&D Officer | - | 2021-10-18 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2024-03-30 | |
| Chairman | - | 2024-03-30 | |
Julien Veys
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-02 | Sell | Chief Operating Officer | 2,825 | 0.0195% | ||
| 04-02 | Buy | Chief Operating Officer | 4,944 | 0.0342% | ||
| 04-02 | Buy | Chief Operating Officer | 4,488 | 0.0310% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +6.35% | -2.62% | +239.07% | +69.19% | 49.57M | |
| +0.13% | +1.50% | +63.86% | +123.95% | 55.63B | |
| +6.76% | +22.83% | +91.66% | +101.42% | 52.25B | |
| +3.33% | +3.71% | -11.68% | -11.82% | 23.07B | |
| +1.32% | +9.33% | +5.28% | +419.80% | 22.41B | |
| +6.78% | +14.47% | +40.28% | -6.67% | 17.32B | |
| +0.97% | +5.01% | +31.23% | -32.10% | 15.94B | |
| -0.89% | +4.57% | +24.30% | +185.83% | 13.77B | |
| +9.96% | +19.81% | +157.65% | +320.70% | 13.47B | |
| +4.21% | +4.76% | +33.21% | - | 12.43B | |
| Average | +3.89% | +5.31% | +67.49% | +130.03% | 22.63B | |
| Weighted average by Cap. | +3.42% | +7.61% | +54.21% | +128.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 11.9M 13.59M 10.98M 10.25M 19.31M 1.29B 19.73M 132M 51M 634M 51.05M 49.93M 2.2B | 4.3M 4.91M 3.97M 3.7M 6.98M 465M 7.13M 47.7M 18.43M 229M 18.45M 18.04M 795M |
| Net Debt | -23.7M -27.07M -21.86M -20.42M -38.46M -2.56B -39.3M -263M -102M -1.26B -102M -99.44M -4.38B | -27.4M -31.3M -25.27M -23.6M -44.47M -2.96B -45.44M -304M -117M -1.46B -118M -115M -5.07B |
Employees
12
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-29 | €3.350 | +6.35% | 45,464 |
| 26-06-26 | €3.150 | -1.25% | 75,503 |
| 26-06-25 | €3.190 | -4.06% | 77,589 |
| 26-06-24 | €3.325 | +0.15% | 84,120 |
| 26-06-23 | €3.320 | +0.91% | 86,154 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.350EUR
Average target price
5.800EUR
Spread / Average Target
+73.13%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHX Stock
Select your edition
All financial news and data tailored to specific country editions
